Janux Therapeutics, Inc. (NASDAQ:JANX), a $2.69 billion market cap biotech company, saw its President and CEO David Alan Campbell recently sell 5,000 shares of the company's common stock.
Following these transactions, the trust holds 293,076 shares of Agilysys (NASDAQ:AGYS). These sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which was established in September ...
As a result of this asset sale, David Kessler has stepped down from his roles within the company. Kessler previously served as Agrify Corporation’s Chief Science Officer, Executive Vice ...
Boeing is donating $1 million to U.S. President-elect Donald Trump's inauguration, a spokesperson for the U.S. planemaker said on Thursday. Boeing says it is donating $1 million to Trump ...